Read More Pharma Industry News LaNova Medicines, AstraZeneca sign $600m worth licensing deal for LM-305 LaNova Medicines has signed an exclusive license deal worth over $600 million for its pre-clinical stage antibody drug… byPallavi MadhirajuMay 14, 2023